Hunter Strategies LLC logo

Microsoft News Tracker

What's more interesting than observing Microsoft?

June 3, 2009

Microsoft acquires assets of Merck unit for Amalga Life Sciences line

Posted by David Hunter at 8:33 PM ET.

Microsoft has announced the acquisition of "certain" assets (for an unspecified amount) of Rosetta Biosoftware, a business unit of Rosetta Inpharmatics LLC, a wholly owned subsidiary of Merck & Co. Inc.

The deal allows Microsoft to incorporate genetic, genomic, metabolomic and proteomics data management software into the Microsoft Amalga Life Sciences platform for enhanced translational research capabilities. In addition, Microsoft will establish a strategic relationship with Merck to enhance the Amalga Life Sciences platform to meet emerging pharmaceutical research needs.

The deal is expected to close at the end of June 2009, and the new Amalga Life Sciences platform incorporating Rosetta Biosoftware technologies is slated to be available in early 2010. Microsoft is pursuing hiring Rosetta Biosoftware employees who can fill roles that are critical to the effective incorporation of Rosetta Biosoftware technologies into the Amalga Life Sciences platform. Until the deal is closed, Rosetta Biosoftware will continue to operate as a business unit of Rosetta Inpharmatics LLC, a wholly owned subsidiary of Merck.

Microsoft rebranded its healthcare software offerings as Amalga in February 2008.



Filed under Acquisitions, Alliances, Coopetition, Healthcare, Merck, Verticals

Related posts:

 

News Search:

Recent Posts:

Daily Digest Email:

Enter your Email


Powered by FeedBlitz

Categories:

Full category list

Archives:

Archive List

RSS Feed:



HunterStrat Links:

Other:

  • Powered by WordPress.

Advertisements:


 

Related:


Misc: